CONTACT: JENNIFER CRONIN
2130 Medical Laboratories
Iowa City IA 52242
(319) 335-5661; fax (319) 335-9917
Release: July 7, 1999
Two UI researchers receive Howard Hughes Medical Institute
IOWA CITY, Iowa Two University of Iowa Health
Care researchers will continue to serve as prestigious Howard Hughes Medical
Institute (HHMI) investigators for the next five years.
HHMI officials have renewed the appointments of Michael
Welsh, M.D., UI professor of internal medicine, and physiology and biophysics;
and Kevin Campbell, Ph.D., UI Foundation Distinguished Professor of physiology
and biophysics, and neurology. The renewal takes effect Sept. 1.
"The College of Medicine is proud to count Dr.
Welsh and Dr. Campbell among our most accomplished faculty," said Robert
P. Kelch, M.D., dean of the UI College of Medicine. "Their research work
holds tremendous promise for clinical medicine. We share the high regard and
confidence in the future of their work as expressed by the Howard Hughes Medical
The institute, based in Maryland, was founded in 1953
by the famous aviator-industrialist Howard Hughes to promote the basic sciences
and the effective application of findings to benefit humankind. The institute
supports investigators at academic medical centers and universities who do
research in cell biology, genetics, immunology, neuroscience and structural
biology. Under agreements worked out with the academic medical centers and
universities, the institute provides salaries, laboratory space and equipment
for the investigators and their research teams.
Welsh joined the UI faculty in 1981. He is internationally
known for his breakthrough research into the genetic causes of cystic fibrosis,
the most common fatal inherited disease in the United States. Welsh originally
became an HHMI investigator in 1989.
Campbell, a UI faculty member since 1981, also became
an HHMI investigator in 1989. Campbell has made numerous discoveries related
to the causes of muscular dystrophy and is involved in trying to find a way
to treat the inherited condition. Muscular dystrophy is a group of diseases
characterized by progressive muscle weakness and degeneration.
In addition to Welsh and Campbell, Val Sheffield,
Ph.D., M.D., UI professor of pediatrics, is an HHMI associate investigator.
He was initially appointed in 1997. John Donelson, Ph.D., UI Foundation Distinguished
Professor and head of biochemistry, previously served as an HHMI investigator.